INI1 (SMARCB1)-deficient primary CNS malignant tumors
Showing 1 - 25 of >10,000
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,
Not yet recruiting
- Rhabdoid Tumor
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 11, 2023
Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)
Recruiting
- Atypical Teratoid/Rhabdoid Tumor
- +17 more
- Atezolizumab
- +7 more
-
Birmingham, Alabama
- +19 more
Feb 2, 2023
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in
Active, not recruiting
- Malignant Rhabdoid Tumors (MRT)
- +10 more
-
San Francisco, California
- +31 more
Jan 17, 2023
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)
Not yet recruiting
- Diffuse Intrinsic Pontine Glioma
- +4 more
- SC-CAR4BRAIN
-
Seattle, WashingtonSeattle Children's Hospital
Mar 3, 2023
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)
Not yet recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
- (no location specified)
Jan 14, 2023
Diffuse Midline Glioma, H3 K27M-Mutant, Metastatic Malignant Tumor in the CNS, Recurrent Diffuse Intrinsic Pontine Glioma Trial
Active, not recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- +10 more
- FACT Complex-targeting Curaxin CBL0137
-
Birmingham, Alabama
- +19 more
Jun 29, 2022
Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Recruiting
- Metastatic Malignant Solid Neoplasm
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Dabrafenib
- MEK-1/MEKK-1 Inhibitor E6201
-
Scottsdale, Arizona
- +2 more
Jan 4, 2023
Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,
Not yet recruiting
- Diffuse Astrocytoma, IDH-Mutant
- +20 more
- NEO212 Oral Capsule
- +8 more
- (no location specified)
Sep 18, 2023
Recurrent Lymphoma, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan,
Active, not recruiting
- Recurrent Lymphoma
- +5 more
- Irinotecan
- +2 more
-
Birmingham, Alabama
- +19 more
Oct 20, 2022
Brain Stem Tumor, Pineal Region Tumor, Recurrent Lymphoma Trial in United States (Entinostat, Laboratory Biomarker Analysis,
Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Irinotecan
Active, not recruiting
- Childhood Solid Neoplasm
- +4 more
- Irinotecan Hydrochloride
- +4 more
-
Birmingham, Alabama
- +20 more
Feb 1, 2023
Metastatic Malignant Solid Tumor, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in United States
Active, not recruiting
- Metastatic Malignant Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 1, 2022
Solid Tumor, Breast Cancer, Small Cell and NSCLC Trial in Hackensack (RAPA-201 Rapamycin Resistant T Cells, Chemotherapy Prior
Recruiting
- Solid Tumor
- +15 more
- RAPA-201 Rapamycin Resistant T Cells
- Chemotherapy Prior to RAPA-201 Therapy
-
Hackensack, New JerseyHackensack University Medical Center
Dec 23, 2021
Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United
Completed
- Neurofibromatosis Type 1
- +4 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, California
- +11 more
Apr 22, 2022
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,
Recruiting
- Advanced Breast Carcinoma
- +73 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
May 5, 2022